Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 588
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00866320 | Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab | ||
| NCT00991991 | Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma | ||
| NCT04765423 | Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease | ||
| NCT02419846 | Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program | ||
| NCT04348123 | Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography | ||
| NCT01155583 | Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma | ||
| NCT02664181 | Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial | ||
| NCT00873600 | Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer | ||
| NCT00258401 | Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. | ||
| NCT02057640 | MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma | ||
| NCT01093586 | Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies | ||
| NCT02073045 | Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery | ||
| NCT02802553 | Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions | ||
| NCT06926530 | Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations | ||
| NCT02661100 | A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients | ||
| NCT03500757 | Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation | ||
| NCT03485937 | Impact of Videos on Patient Anxiety and Satisfaction | ||
| NCT02666183 | Online Information and Support for Distance Caregivers | ||
| NCT00003768 | Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors | ||
| NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | ||
| NCT00853021 | Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney | ||
| NCT06421155 | Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia | ||
| NCT00278174 | Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer | ||
| NCT02100423 | Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||
| NCT05028621 | Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease | ||
| NCT02065596 | Hematopoietic Stem Cell Transplant for Sickle Cell Disease | ||
| NCT00003114 | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease | ||
| NCT00253344 | Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors | ||
| NCT06435871 | Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors | ||
| NCT04055948 | Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients | ||
| NCT00027885 | Phase II Bevacizumab + Tax In Advanced Breast Cancer | ||
| NCT05210374 | Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas | ||
| NCT00006018 | Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors | ||
| NCT00006465 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | ||
| NCT01465113 | Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus | ||
| NCT03122470 | Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer | ||
| NCT00006259 | Stereotactic Radiation Therapy in Treating Patients With Brain Metastases | ||
| NCT02055586 | FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents | ||
| NCT01340599 | Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery | ||
| NCT00970684 | Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | ||
| NCT03272880 | Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers | ||
| NCT02790294 | Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal | ||
| NCT00077103 | Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer | ||
| NCT00905086 | Psychosocial Adjustment After Radiation Therapy in Patients With Cancer | ||
| NCT00055640 | Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma | ||
| NCT01800838 | Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma | ||
| NCT00460031 | Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | ||
| NCT00736216 | Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults | ||
| NCT01704885 | A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer | ||
| NCT02588651 | A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) |
